The content of steroid hormones in the mitochondria of unchanged and tumor tissue of the uterine body
https://doi.org/10.37748/2686-9039-2025-6-4-1
EDN: MCNNID
Abstract
Mitochondria regulate a wide range of processes, including stress responses, metabolism, immunity, differentiation, redox homeostasis, and steroidogenesis, and also serve as the principal intracellular source of reactive oxygen species (ROS). Mitochondrial dysfunction has been linked to the development of various pathological conditions, including the growth of both benign and malignant tumors.
Purpose of the study. Determination of the level of steroid hormones in the mitochondria of various tissues of the uterine body.
Materials and methods. The study included 65 patients with benign and malignant diseases of the uterus: 25 patients with endometrioid adeno‑ carcinoma of the uterus (EAC) of low differentiation (G3) stage II–III; 15 patients with leiomyosarcoma of the uterus stage I–III; and 25 patients with uterine myoma. Mitochondria from native samples of uterine tumors were isolated by differential centrifugation in a high-speed refrigerated centrifuge Avanti J-E, Becman Coulter. For the comparison group, mitochondria were isolated from intact uterine tissue. The levels of estradiol (E2), testosterone (T), progesterone (P4), and cortisol were determined using standard ELISA kits (Monobind, USA) in mitochondria isolated from the indicated tissues. A statistical analysis of the results was conducted using the Statistica 10.0 software package.
Results. Irrespective of the nature of the tumor process (benign or malignant), a decrease in the P4 level by 2.7 to 9.1 times, but an increase in the content of cortisol by 1.3 to 3.7 times and T by 2.1 to 3.7 times were detected in the mitochondria of uterine tumors. Conversely, the concentration of E2 in the mitochondria of uterine fibroids exhibited an increase of 2.2 times compared to the indicators in the mitochondria of the intact uterus. No significant differences were observed in the mitochondria of EAC, while a decrease of 1.4 times was noted in the mi‑ tochondria of uterine sarcoma.
Conclusion. There is a change in the content of steroid hormones in In the mitochondria of uterine tumors, consisting in an increase in the concentrations of cortisol and testosterone and progesterone deficiency regardless of the type of pathology, but a relative or absolute defi‑ ciency of estrogens only in the mitochondria of malignant tumors. Changes in the steroid background of tumor mitochondria, compared with the mitochondria of the intact uterus, probably have a significant effect on both the energy balance of cells and the production of ROS, as well as on proliferative processes.
About the Authors
E. M. FrantsiyantsNational Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Elena M. Frantsiyants – Dr. Sci. (Biology), Professor, Deputy General Director for Science, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0003-3618-6890, eLibrary SPIN: 9427-9928, AuthorID: 462868, Scopus Author ID: 55890047700
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
V. А. Bandovkina
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Valerija A. Bandovkina – Dr. Sci. (Biology), Leading Researcher at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-2302-8271, eLibrary SPIN: 8806-2641, AuthorID: 696989, Scopus Author ID: 57194276288
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
T. I. Moiseenko
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Tatiana I. Moiseenko – Dr. Sci. (Medicine), Professor, Chief Researcher, Department of Oncogynecology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-9683-2164, eLibrary SPIN: 6341-0549, AuthorID: 705829, Scopus Author ID: 57194270696
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
A. P. Menshenina
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Anna P. Menshenina – Dr. Sci. (Medicine), ociate Professor, Leading Researcher at the Department of Oncogynecology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-7968-5078, eLibrary SPIN: 6845-4794, AuthorID: 715810, Scopus Author ID: 57191983118
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
Yu. A. Petrova
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Yulia A. Petrova – Cand. Sci. (Biology), Senior Researcher at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-2674-9832, eLibrary SPIN: 2168-8737, AuthorID: 558241, Scopus Author ID: 37026863400
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
I. V. Neskubina
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Irina V. Neskubina – Dr. Sci. (Biology), Senior Researcher at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-7395-3086, eLibrary SPIN: 3581-8531, AuthorID: 794688, Scopus Author ID: 6507509066
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
L. K. Trepitaki
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Lidija K. Trepitaki – Cand. Sci. (Biology), Research Fellow at Laboratory of Study of Malignant Tumor Pathogenesis, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID ID: https://orcid.org/0000-0002-9749-2747, eLibrary SPIN: 2052-1248, AuthorID: 734359, Scopus Author ID: 55357624700
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
E. I. Surikova
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Ekaterina I. Surikova – Cand. Sci. (Biology), Senior Researcher at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-4318-7587, eLibrary SPIN: 2401-4115, AuthorID: 301537, Scopus Author ID: 6507092816
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
M. A. Rogozin
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Mark A. Rogozin – graduate student, Section of Reproductive Tumors, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0009-0003-7909-2883, eLibrary SPIN: 3965-1806, AuthorID: 1238353
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
N. D. Cheryarina
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Nataliya D. Cheryarina – laboratory assistant at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-3711-8155, eLibrary SPIN: 2189-3404, AuthorID: 558243, Scopus Author ID: 56204439400
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
E. A. Ozerkova
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Elena A. Ozerkova – oncologist, clinical diagnostic department, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0009-0005-8658-8902; eLibrary SPIN: 8708-7013, AuthorID: 1277468
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
O. E. Zhenilo
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Oksana E. Zhenilo – Cand. Sci. (Medicine), researcher, Department of Oncogynecology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-9833-8530, eLibrary SPIN: 4078-7080, AuthorID: 732220
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
N. A. Maximova
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Nataly A. Maximova – Dr. Sci. (Medicine), Professor, Head of Radioisotope Laboratory with Ultrasonic Diagnostics Group, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-0400-0302, eLibrary SPIN: 1785-9046, AuthorID: 375005, Scopus Author ID: 57211495326
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
O. V. Bykadorova
Rostov-on-Don, Russian Federation
Oksana V. Bykadorova – functional diagnostics doctor, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0003-4644-5171, eLibrary SPIN: 4814-9722, AuthorID: 961513
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
A. A. Vereskunova
Rostov State Medical University
Rostov-on-Don, Russian Federation
Aleksandra A. Vereskunova – student, Rostov State Medical University, Rostov-on-Don, Russian Federation ORCID ID: https://orcid.org/0000-0001-7017-3781, eLibrary SPIN: 9337-9697, AuthorID: 1161679
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
A. O. Adamyan
Rostov State Medical University
Rostov-on-Don, Russian Federation
Alla O. Adamyan – student, Rostov State Medical University, Rostov-on-Don, Russian Federation
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
References
1. Al-Suhaimi E, 2024. Al-Suhaimi E, AlQuwaie R, AlSaqabi R, Winarni D, Dewi FRP, AlRubaish AA, Shehzad A, Elaissari A. Hormonal orchestra: mastering mitochondria's role in health and disease. Endocrine. 2024;86(3):903–929. https://doi.org/10.1007/s12020-024-03967-1
2. Vodicka P, Vodenkova S, Danesova N, Vodickova L, Zobalova R, Tomasova K, et al. Mitochondrial DNA damage, repair, and replacement in cancer. Trends Cancer. 2025 Jan;11(1):62–73. https://doi.org/10.1016/j.trecan.2024.09.010
3. Vahedi Raad M, Firouzabadi AM, Tofighi Niaki M, Henkel R, Fesahat F. The impact of mitochondrial impairments on sperm function and male fertility: a systematic review. Reprod Biol Endocrinol. 2024;22(1):83. https://doi.org/10.1186/s12958-024-01252-4
4. Liao RG, Wang JH, Zhang F, Fang YT, Zhou L, Zhang YQ. A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma. Sci Rep. 2025;15(1):1404. https://doi.org/10.1038/s41598-025-85537-7
5. Wang SF, Tseng LM, Lee HC. Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci. 2023;30(1):61. https://doi.org/10.1186/s12929-023-00956-w
6. Chen JQ, Yager JD. Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis. Ann N Y Acad Sci. 2004; 1028:258–272. https://doi.org/10.1196/annals.1322.030
7. Kit OI, Vodolazhsky DI, Kutilin DS, Moiseenko TI, Nikitin IS, Frantsiyants EM. Changes in expression of estrogen-regulatory genes in malignancy uterine tissues. Kuban Scientific Medical Bulletin. 2016;157(2):84–90. (In Russ.).
8. Lejri I, Grimm A, Eckert A. Mitochondria, Estrogen and Female Brain Aging. Front Aging Neurosci. 2018;10:124. https://doi.org/10.3389/fnagi.2018.00124
9. Liao TL, Lee YC, Tzeng CR, Wang YP, Chang HY, Lin YF, Kao SH. Mitochondrial translocation of estrogen receptor β affords resistance to oxidative insult-induced apoptosis and contributes to the pathogenesis of endometriosis. Free Radic Biol Med. 2019;134:359–373. https://doi.org/10.1016/j.freeradbiomed.2019.01.022
10. Feng Q, Crochet JR, Dai Q, Leppert PC, Price TM. Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential. J Clin Endocrinol Metab. 2014 Mar;99(3):E390–9. https://doi.org/10.1210/jc.2013-2008
11. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. https://doi.org/10.1126/science.1160809
12. DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200. https://doi.org/10.1126/sciadv.1600200
13. Egorova MV, Afanasyev SA. Isolation of mitochondria from cells and tissues of animals and human: modern methodical approaches. Siberian Medical Journal. 2011;26(1–1):22–28. (In Russ.).
14. Gureev AP, Kokina AV, Sy`romyatnikova MYu, Popov VN. Optimization of methods for isolating mitochondria from different mouse tissues. Proceedings of Voronezh State University. Series: Chemistry. Biology. Pharmacy. 2015;4:61–65. (In Russ.).
15. Midzak A, Papadopoulos V. Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies. Front Endocrinol (Lausanne). 2016;7:106. https://doi.org/10.3389/fendo.2016.00106
16. Shen K, Pender CL, Bar-Ziv R, Zhang H, Wickham K, Willey E, Durieux J, Ahmad Q, Dillin A. Mitochondria as Cellular and Organismal Signaling Hubs. Annu Rev Cell Dev Biol. 2022;38:179–218. https://doi.org/10.1146/annurev-cellbio-120420-015303
17. Casanova A, Wevers A, Navarro-Ledesma S, Pruimboom L. Mitochondria: It is all about energy. Front Physiol. 2023;14:1114231. https://doi.org/10.3389/fphys.2023.1114231
18. Bassi G, Sidhu SK, Mishra S. The Expanding Role of Mitochondria, Autophagy and Lipophagy in Steroidogenesis. Cells. 2021;10(8):1851. https://doi.org/10.3390/cells10081851
19. Ham J, Song J, Song G, Lim W. Autophagy regulation and redox perturbation by transcrocetin suppress the growth of endometriosis. Biomed Pharmacother. 2024 Apr;173:116284. https://doi.org/10.1016/j.biopha.2024.116284
20. Blalock ZN, Wu GWY, Lindqvist D, Trumpff C, Flory JD, Lin J, et al.; SBPBC; Doyle FJ 3rd, Marmar CR, Jett M, Yehuda R, Wolkowitz OM, Mellon SH. Circulating cell-free mitochondrial DNA levels and glucocorticoid sensitivity in a cohort of male veterans with and without combat-related PTSD. Transl Psychiatry. 2024;14(1):22. https://doi.org/10.1038/s41398-023-02721-x
21. Sachdeva K, Do DC, Zhang Y, Hu X, Chen J, Gao P. Environmental exposures and Asthma Development: Autophagy, Mitophagy, and Cellular Senescence. Front Immunol. 2019;10:2787. https://doi.org/10.3389/fimmu.2019.02787
22. Liu Z, Gou Y, Zhang H, Zuo H, Zhang H, Liu Z, Yao D. Estradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall. Redox Biol. 2014;3:88–99. https://doi.org/10.1016/j.redox.2014.11.001
23. Xie B, Chen Q, Dai Z, Jiang C, Chen X. Progesterone (P4) ameliorates cigarette smoke-induced chronic obstructive pulmonary disease (COPD). Mol Med. 2024;30(1):123. https://doi.org/10.1186/s10020-024-00883-y
24. Zhang X, Bao W, Fei X, Zhang Y, Zhang G, Zhou X, et al. Progesterone attenuates airway remodeling and glucocorticoid resistance in a murine model of exposing to ozone. Mol Immunol. 2018;96:69–77. https://doi.org/10.1016/j.molimm.2018.02.009
25. Hall OJ, Limjunyawong N, Vermillion MS, Robinson DP, Wohlgemuth N, Pekosz A, et al. Progesterone-based therapy protects against influenza by promoting lung repair and recovery in females. PLoS Pathog. 2016;12(9):e1005840. https://doi.org/10.1371/journal.ppat.1005840
26. Gaignard P, Frechou M, Schumacher M, Therond P, Mattern C, Slama A, et al. Progesterone reduces brain mitochondrial dysfunction after transient focal ischemia in male and female mice. J Cereb Blood Flow Metab. 2016;36(3):562–568. https://doi.org/10.1177/0271678x15610338
27. Yin L, Luo M, Wang R, Ye J, Wang X. Mitochondria in Sex Hormone-Induced Disorder of Energy Metabolism in Males and Females. Front Endocrinol (Lausanne). 2021 Dec 20;12:749451. https://doi.org/10.3389/fendo.2021.749451
28. Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018(2):121– 135. https://doi.org/10.1038/nrm.2017.95
29. Bajpai P, Koc E, Sonpavde G, Singh R, Singh KK. Mitochondrial localization, import, and mitochondrial function of the androgen receptor. J Biol Chem. 2019;294(16):6621–6634. https://doi.org/10.1074/jbc.ra118.006727
30. Navarro G, Allard C, Morford JJ, Xu W, Liu S, Molinas AJ, et al. Androgen excess in pancreatic β cells and neurons predisposes female mice to type 2 diabetes. JCI Insight. 2018;3(12):e98607. https://doi.org/10.1172/jci.insight.98607
31. Arjmand S, Ilaghi M, Sisakht AK, Guldager MB, Wegener G, Landau AM, Gjedde A. Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review. Basic Clin Pharmacol Toxicol. 2024;135(2):115–132. https://doi.org/10.1111/bcpt.14035
32. Wang Y, Ji Q, Cao N, Ge G, Li X, Liu X, Mi Y. CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function. Cancer Metab. 2024;12(1):33. https://doi.org/10.1186/s40170-024-00360-4
33. Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021 Jan 8;49(D1):D1541–D1547. https://doi.org/10.1093/nar/gkaa1011
34. Jia Y, Yee JK, Wang C, Nikolaenko L, Diaz-Arjonilla M, Cohen JN, et al. Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress. Am J Physiol Endocrinol Metab. 2018;314(4):E366–E376. https://doi.org/10.1152/ajpendo.00124.2017
35. Yin L, Luo M, Wang R, Ye J, Wang X. Mitochondria in Sex Hormone-Induced Disorder of Energy Metabolism in Males and Females. Front Endocrinol (Lausanne). 2021;12:749451. https://doi.org/10.3389/fendo.2021.749451
36. Martínez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11(1):102. https://doi.org/10.1038/s41467-019-13668-3.
Review
For citations:
Frantsiyants E.M., Bandovkina V.А., Moiseenko T.I., Menshenina A.P., Petrova Yu.A., Neskubina I.V., Trepitaki L.K., Surikova E.I., Rogozin M.A., Cheryarina N.D., Ozerkova E.A., Zhenilo O.E., Maximova N.A., Bykadorova O.V., Vereskunova A.A., Adamyan A.O. The content of steroid hormones in the mitochondria of unchanged and tumor tissue of the uterine body. South Russian Journal of Cancer. 2025;6(4):6-15. https://doi.org/10.37748/2686-9039-2025-6-4-1. EDN: MCNNID























